Blood Culture Tests Market Growth Drivers and Challenges:
Growth Drivers
- Growth Strategies Integration by Market Players - Growth strategies include new product launches, mergers and acquisitions, obtaining investment from prominent companies to provide consumers with innovative and safe products, strengthening our product offerings, expanding our customer base, and expanding our market reach. This includes strengthening our presence and expanding our geographic footprint. We are currently seeing an increasing trend in the market towards these strategies. In March 2023, BARDA and BioFire Defense, LLC partnered to advance the development of Specific Diagnostics' SPECIFIC Reveal Rapid AST system. The platform is designed to test for antibiotic susceptibility in a rapid and modular manner, providing phenotypic results from positive blood cultures or isolates in an average of just 5.5 hours. Thus, growing number of growth strategies introduced by market players is significantly driving the expansion of the market in the estimated timeframe.
- Blood Culture Out Space Solid Media Culture Plates - The requirement for a lengthy culture period on solid media has been considered a limitation of MALDI-TOF, as it delays time to patient diagnosis. By comparison, nucleic acids isolated directly from biological samples can be subjected to molecular techniques such as polymerase chain reaction (PCR) and do not require additional incubation time. The concentration of host proteins also contributes to the bacterially attributed and masked spectral information, making it impossible to analyze microorganisms using MALDI-TOF directly from biological samples such as blood or urine.
Challenges
- Lack of Skilled Laboratory Technicians - It is well known that lab-based diagnostic tests are the most important volume activity of the medical industry. In almost all cases, patients who visit a healthcare establishment are treated with clinical laboratory tests. Despite the growing demand for skilled workers in the laboratory sector, there is a severe shortage of them.
- False Positive Results of the Test are Expected to Hamper the Market Growth in the Forecast Period
- High Cost of Test is Set to Pose Limitation on the Market Growth in the Upcoming Period
Blood Culture Tests Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
10.6% |
|
Base Year Market Size (2025) |
USD 6.83 billion |
|
Forecast Year Market Size (2035) |
USD 18.71 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of blood culture tests is estimated at USD 7.48 billion.
The global blood culture tests market size crossed USD 6.83 billion in 2025 and is likely to expand at a CAGR of around 10.6%, surpassing USD 18.71 billion revenue by 2035.
Asia Pacific blood culture tests market will secure around 33% share by 2035, driven by the rising importance of blood cultures in combating antibiotic resistance, particularly in South Asia.
Key players in the market include F. Hoffmann-La Roche AG, Cepheid, Scenker Biological Technology Co., Ltd, Bio-Rad Laboratories, Inc., TERUMO BCT, INC., bioMérieux SA.
